From CBD Oils to Beauty: How CBD Found Its Premium Place in Finland
CBD skincare Finland is moving from niche curiosity to a considered beauty category.
Blank& is one of the brands shaping that shift through clear design and documented sourcing. The brand combines Ecocert-certified ingredients with European hemp and rigorous lab testing. Retailers and consumers now evaluate CBD products by proof, not hype.
The market still faces three main challenges. First, regulatory complexity makes product registration and labeling difficult. Second, inconsistent raw material sourcing creates wide quality variation. Third, cosmetic formulators must manage terpene and minor-cannabinoid profiles differently from supplement makers.
This article profiles how Blank&, led by Miro Koliseva, navigated those challenges. It explains supplier choices, compliance steps, and retail positioning in Finland. Practical takeaways follow for brands looking to launch premium CBD cosmetics in Europe.
Read the full case study of Blank& here.
Read the case study on CBD oil use for rosacea management here.
Key takeaways
- Position for trust: lead with provenance, Ecocert and simple usage guidance.
- Price by channel: test a premium pharmacy tier and an accessible wellness tier; keep a MAP.
- Prefer low-terpene, broad-spectrum European hemp and verify origin.
- Do final bottling locally to shorten lead times and control labelling.
- Require a supplier SLA for rapid COA/replacement and hold buffer stock.
- Send a one-page retail kit (sample + COA snapshot + CPNP note) and track time-to-shelf, sell-through and reorder rate.
Market context and regulatory landscape
Cosmetics in the EU are governed by Regulation (EC) No 1223/2009. It sets safety, labeling and market-surveillance rules for finished products. Before a cosmetic is sold in the EU, it must be notified in the Cosmetic Products Notification Portal (CPNP). CPNP is the central database used by authorities and poison centres.
CBD is not outright banned in cosmetics, but it requires careful handling. Raw-material COAs must show THC compliance and a clear origin. Extraction method and plant part can affect regulatory scrutiny. Keep full lab reports and supplier documentation ready for retailers or authorities.
In Finland, the competent authority is Tukes, which performs market surveillance rather than pre-approval. Brands must designate an EU Responsible Person and keep a complete Product Information File (PIF) with safety assessment, formula and COAs. The three front-line tasks for any Finnish launch are: confirm COAs and THC limits (0,2%), assemble the PIF, and notify the finished product in CPNP before placing it on the market.
Sourcing and quality: European hemp vs US isolates
Brands choose between CBD isolate and hemp extracts. Isolate is almost pure CBD and gives a clean, neutral ingredient to work with. Hemp extracts (broad- or full-spectrum) carry minor cannabinoids and terpenes, which affect scent, skin feel and the way formulators design actives and fragrances. Regulators and retailers also view extracts differently: extracts need fuller COAs and origin tracing, while isolates are simpler to document.
Many premium brands prefer European hemp because it is easier to trace back to farms and show a documented origin. Suppliers can tailor broad-spectrum extracts to lower terpene levels, so the ingredient behaves like a subtle functional booster rather than a perfume. Be mindful that some terpenes can sensitize skin at high concentrations; cosmetic formulators often ask for restrained terpene profiles and explicit lab methods. (Myswisslab)
“We wanted European hemp, not US isolates. Traceability and the right minor-cannabinoid mix mattered for skin performance.” — Miro Koliseva, Blank&
Make sure you always request a full COA (cannabinoids + terpenes), a supplier origin declaration and a low-terpene or custom-profile option if you need a neutral, non-fragranced cosmetic ingredient.
Formulation decisions: cannabinoids and terpenes
Formulators choose ingredients to balance performance, safety and scent. CBD and some minor cannabinoids can reduce inflammation and support skin balance when used topically. Evidence for topical benefits is growing but still selective.
Terpenes can help absorption and modulate activity, but some oxidised terpenes are known skin sensitizers. That means formulators often ask suppliers for low-terpene or custom-tailored profiles so the extract acts like a subtle active, not a perfume. Always check COAs for terpene breakdown and ask about antioxidant/storage measures that limit terpene oxidation.
| Component | Cosmetic benefit (what brands care about) | Practical note |
|---|---|---|
| CBD | Anti-inflammatory, antioxidant support | Check topical studies and ensure appropriate concentration. (PMC) |
| CBG / other minors | Promising for barrier support and anti-inflammatory action | Early data looks good; label carefully and keep COAs. (Labhemp.) |
| Linalool / limonene (terpenes) | Fragrance / potential synergistic effects | Can oxidise into sensitizers; prefer low-terpene profiles for face products. (PMC) |
Product registration, testing and documentation workflow
Bringing a CBD cosmetic to market is mostly paperwork done right. The core legal requirement is the Product Information File (PIF) and a valid Cosmetic Product Safety Report (CPSR) prepared by a qualified safety assessor. The Responsible Person must hold these documents and notify the finished product in the CPNP before placing it on the EU market. Regulators or retail buyers will ask to see them at any time.
Testing is driven by three needs: safety, identity, and traceability. Typical tests include a full cannabinoid profile (CBD, CBG, minor cannabinoids), THC quantification, terpene breakdown if relevant, residual solvents, pesticides/heavy metals, microbiology, preservative efficacy and stability. Labs must report methods and LOQs so authorities can understand limits and comparability. Keep every COA and method statement inside the PIF.
Essentia Pura’s role for Blank& was practical: provide CPNP-ready material with clear COAs and a supplier declaration, and support the brand when a minor bottling issue appeared. That meant Blank& could assemble the PIF faster and supply retailers with the documentation they required. Practical support from a supplier shortens review cycles and reduces back-and-forth with market surveillance.
Launch-ready checklist:
- Responsible Person designated (EU address + contact)
- Cosmetic Product Safety Report (CPSR) completed by a qualified safety assessor
- Full COA: cannabinoids, THC, terpene profile (if used), heavy metals, pesticides
- Stability data or stability rationale for shelf life and storage conditions
- Preservative Efficacy Test (if product is water-containing)
- Supplier declaration: origin, extraction method, batch traceability
- Label copy and translation files saved (ingredient list, warnings, batch code)
- CPNP notification completed and confirmation saved (UIN/reference)
- Scanned lab methods and LOQs included for regulator transparency
Production, bottling and supply-chain choices
Blank& did final bottling in Finland to keep control over packaging, labelling and timing. Local filling can cut lead times and lower transit risk for finished goods.
A transparent supplier matters more than the lowest price. When suppliers deliver quick COAs, clear batch traceability, and fast turnaround, brands can react to issues and satisfy retail or regulatory requests. Traceability also supports sustainability and retailer trust.
Keep buffer stock at the bottling site and plan contingencies. Safety stock or a small emergency reserve prevents a single supplier delay from stopping shipments. Simple contingency planning shortens recovery time.
--> Fun fact: Broad-spectrum extracts can be post-processed (dearomatised) to remove most terpenes while keeping minor cannabinoids, so you get a plant-derived active that behaves almost odorless and is thus ideal for fragrance-free face and intimate-care products.
Retail rollout: positioning, pricing and distribution
Positioning matters more than a product sheet.
Blank& framed CBD as progressive luxury. The brand leaned on clean visuals, simple usage instructions and evidence-forward messaging. That made the product easier to place in stores where trust matters. Train store staff with a short demo script and a single-page sell sheet so they can answer questions quickly.
Pricing and distribution rules must be deliberate.
Test two price tiers: one premium tier for pharmacy and specialty beauty, and one accessible tier for wellness stores and online bundles. Use a clear MAP policy so retailers do not undercut each other. Offer a low-risk trial pack for first-time buyers and a reorder incentive for early retail partners. Track sell-through and adjust facing counts or reorder frequency rather than dropping price.
Make retail trials low-friction.
Accept small first orders and promise fast replenishment. Offer a simple retail kit with a sample, a short usage card and a one-line compliance note. For pharmacy placements, focus on provenance and consumer trust. For lifestyle shops, focus on design and sensory fit.
About us
At Essentia Pura, we specialize in manufacturing high-quality white-label and private-label CBD products, helping businesses launch their own unique CBD brands. With cutting-edge hemp extraction methods and a commitment to compliance and quality, we support companies in the nutraceutical, pharmaceutical, and cosmetic industries. Whether you’re looking for ready-to-market formulations or custom solutions, we’re here to help you succeed in the growing CBD market.
